![](https://endpts.com/wp-content/uploads/2019/06/insys-tile-from-glassdoor-enders.jpg)
Battered by legal expenses, opioid drugmaker Insys files for bankruptcy days after $225M deal to settle government probes
To nobody’s surprise, controversial opioid drugmaker Insys is filing for bankruptcy.
Last week, the company $INSY agreed to pay $225 million to settle the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.